Surgery is a cost-effective option in treating upper arm fractures
24.3.2026 12:08:43 EET | HUS | Press release
A Finnish randomized study showed that surgery of upper arm fractures is more cost-effective for society than treatment with a brace.

Upper arm fractures are common especially in adults of working age. The injury can lead to prolonged absence from work causing significant costs both for the individual and for society.
“Previous studies have found that surgery and bracing produce a similar functional outcome on average, but there has not been sufficient information on the cost-effectiveness of these treatment methods,” says HUS’ resident Cyrill Suter, who is one of the lead authors of the study article.
The newly published economic evaluation is based on a Finnish randomized study named FISH (Finnish Shaft of the Humerus) conducted at two university hospitals. The study article was published in The Journal of Bone & Joint Surgery. The study included 82 adult patients at HUS Helsinki University Hospital and Tampere University Hospital. The patients had suffered an upper arm fracture and were randomly assigned either to surgery or functional bracing and then followed for two years.
Surgery is cheaper from society’s point of view
“We looked at total cost-effectiveness from both societal and health care perspective. In the societal analysis, we also took into account the losses due to work absences. In that perspective, surgical treatment proved to be both more effective and less costly overall,” says researcher and specialist Thomas Ibounig.
The average total cost per patient was EUR 23,680 in the surgery group and EUR 30,389 in the bracing group. Health benefits were measured in quality-adjusted life years (QALY). The QALYs gained were slightly higher in the surgery group after two-year follow-up.
Decision-making must consider patient’s life situation and broader societal impacts of treatment
When the analysis was narrowed down to just direct healthcare costs, the situation changed: functional bracing was less expensive and therefore more cost-effective.
According to the researchers, the results highlight the importance of perspective when evaluating various treatment methods.
“If we take into account the restoration of work ability and the economic impacts of that, surgery is a justified option, particularly for working-age patients,” says Suter.
Functional bracing is still a viable and economically sound solution for patients whose absence from work does not cause significant costs and whose individual factors support conservative treatment.
Head Physician Lasse Rämö from HUS Orthopedics and Traumatology considers the study significant: “The results support shared decision-making, in which both the patient's life situation and the broader societal impacts of treatment are taken into account.”
Link to the research article: Cost-Effectiveness of Surgery Versus Functional Bracing for Humeral Shaft Fractures in Adults
In university hospitals research is part of treatment: new research outcomes make treatment practises more efficient and help focus treatments correctly. We work in close collaboration with the University of Helsinki and other universities, and we publish ca 3,000 peer-reviewed research articles annually.
Today’s research provides better care in the future.
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
Contacts
Cyrill SuterMD, resident in orthopedics and traumatology, HUS
cyrill.suter@hus.fiLasse RämöMD, PhD, specialist in orthopedics and traumatology, HUS
lasse.ramo@hus.fiThomas IbounigM.D., Specialist in Orthopedics and Traumatology, FICEBO Research Group
Tel:+358 40 356 7693thomas.ibounig@hus.fiImages

About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Lovande resultat vid betainbehandling av den sällsynta sjukdomen AGU20.11.2026 08:01:27 EET | Pressmeddelande
En studie ger nytt hopp till barn som lider av den sällsynta sjukdomen aspartylglukosaminuri (AGU) och deras familjer. Studien visar att intag av betain avsevärt kan förbättra ämnesomsättningen hos barn med AGU samt främja deras kognitiva och fysiska prestationsförmåga.
Betaiinihoidosta lupaavia tuloksia harvinaista AGU-tautia sairastaville20.11.2026 08:01:27 EET | Tiedote
Tutkimus tuo uutta toivoa harvinaista aspartylglukosaminuriaa (AGU) sairastaville lapsille ja heidän perheilleen. Tutkimus osoittaa, että betaiinin käyttö voi parantaa merkittävästi AGU:a sairastavien lasten aineenvaihduntatasoja sekä edistää heidän kognitiivista ja fyysistä suoriutumistaan.
Promising results from betaine in treatment of the rare AGU disease20.11.2026 08:01:27 EET | Press release
A study brings hope to children living with aspartylglucosaminuria (AGU) and their families. The study shows that betaine can significantly improve metabolism in children with AGU and promote their cognitive and physical performance.
Fynd i sköljvätska från munnen kan bidra till en bättre förståelse av långtidscovid19.11.2026 10:44:44 EET | Pressmeddelande
I en studie genomförd av HUS och Helsingfors universitet upptäcktes fler inflammationsmarkörer i vatten som patienter med långtidscovid hade sköljt munnen med än hos kontrollgruppen. Observationen kan bidra till en bättre förståelse av vad som händer i kroppen under en långvarig coronasjukdom.
Suun huuhtelunesteen löydökset voivat auttaa ymmärtämään long covidia paremmin19.11.2026 10:44:44 EET | Tiedote
HUSin ja Helsingin yliopiston tutkimuksessa long covid -potilaiden suun huuhtelunesteestä löytyi enemmän tulehdukseen liittyviä merkkiaineita kuin vertailuryhmältä. Havainto voi auttaa ymmärtämään tarkemmin, mitä elimistössä tapahtuu pitkittyneen koronataudin aikana.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom